Ann M. Hanly

This profile gathers the share dealings of Ann M. Hanly in Vir Biotechnology, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 29 March 2021 to 24 February 2025, the count stands at 11 filings.

Both buying and selling appear: 1 purchase worth €443, against 6 sales worth €440k. Taken together, the sales exceed the purchases by €440k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants. Since January 2025: no purchases and 1 sale on the market.

The record was last updated on 25 February 2025 with an open-market sale (€128k) in Vir Biotechnology, Inc. The clock since the last published purchase (1 December 2021) now reads 1,803 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.